521 related articles for article (PubMed ID: 19171081)
1. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
[TBL] [Abstract][Full Text] [Related]
2. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
3. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
[TBL] [Abstract][Full Text] [Related]
4. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
Boshra H; Lorenzo G; Rodriguez F; Brun A
Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
[TBL] [Abstract][Full Text] [Related]
5. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
Wallace DB; Ellis CE; Espach A; Smith SJ; Greyling RR; Viljoen GJ
Vaccine; 2006 Nov; 24(49-50):7181-9. PubMed ID: 16870311
[TBL] [Abstract][Full Text] [Related]
6. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
8. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of three candidate Rift Valley fever vaccines in sheep.
Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
[TBL] [Abstract][Full Text] [Related]
11. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
Bhardwaj N; Heise MT; Ross TM
PLoS Negl Trop Dis; 2010 Jun; 4(6):e725. PubMed ID: 20582312
[TBL] [Abstract][Full Text] [Related]
13. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
14. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
15. Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera.
Paweska JT; Smith SJ; Wright IM; Williams R; Cohen AS; Van Dijk AA; Grobbelaar AA; Croft JE; Swanepoel R; Gerdes GH
Onderstepoort J Vet Res; 2003 Mar; 70(1):49-64. PubMed ID: 12825681
[TBL] [Abstract][Full Text] [Related]
16. Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens.
Lorenzo G; Martín-Folgar R; Hevia E; Boshra H; Brun A
Vaccine; 2010 Apr; 28(17):2937-44. PubMed ID: 20188678
[TBL] [Abstract][Full Text] [Related]
17. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus.
Kortekaas J; Dekker A; de Boer SM; Weerdmeester K; Vloet RP; de Wit AA; Peeters BP; Moormann RJ
Vaccine; 2010 Mar; 28(11):2271-6. PubMed ID: 20079874
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential vectors of and detection of antibodies against Rift Valley fever virus in livestock during interepizootic periods.
Rostal MK; Evans AL; Sang R; Gikundi S; Wakhule L; Munyua P; Macharia J; Feikin DR; Breiman RF; Njenga MK
Am J Vet Res; 2010 May; 71(5):522-6. PubMed ID: 20433377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]